The signaling pathway for tumor necrosis factor-α (TNF-α) and its receptors is up-regulated during extracorporeal circulation (ECC), and recruits blood neutrophil into the lung tissue, which results in acute lung injury (ALI). In this study, we evaluated the role of tumor necrosis factor receptor 1 (TNFR1) in ECC-induced ALI by blocking TNF-α binding to TNFR1 with CAY10500. Anesthetized Sprague-Dawley (SD) rats were pretreated intravenously with phosphate buffered saline (PBS) or vehicle (0.3 ml ethanol IV) or CAY10500, and then underwent ECC for 2 h. The oxygenation index (OI) and pulmonary inflammation were assessed after ECC. OI was significantly decreased, while TNF-α and neutrophil in bronchoalveolar lavage fluid (BALF) and plasma TNF-α increased after ECC. Pretreatment of CAY10500 decreased plasma TNF-α level, but did not decrease TNF-α levels and neutrophil counts in BALF or improve OI. Lung histopathology showed significant alveolar congestion, infiltration of the leukocytes in the airspace, and increased thickness of the alveolar wall in all ECC-treated groups. CAY10500 pretreatment slightly reduced leukocyte infiltration in lungs, but did not change the wet/dry ratio in the lung tissue. Blocking TNF-α binding to TNFR1 by CAY10500 intravenously slightly mitigates pulmonary inflammation, but cannot improve the pulmonary function, indicating the limited role of TNFR1 pathway in circulating inflammatory cell in ECC-induced ALI.
Introduction
Acute lung injury (ALI) is one of the most common complications following extracorporeal circulation (ECC), and the mortality rate in its severe form, acute respiratory distress syndrome (ARDS), is very high (Ng et al., 2002; Staton et al., 2005) . ALI associated with ECC, characterized with pulmonary inflammation, is primarily believed to be due to systemic inflammatory response syndrome (SIRS) (Zhou et al., 2008; 2010; Tao et al., 2009) . After activated by plasma proinflammatory mediators, neutrophils are recruited in alveolar spaces due to chemokines Li et al., 2012) , and further release proteolytic enzymes and free radicals, which can cause damages to pulmonary endothelial cells as well as epithelial cells, leading to increased pulmonary alveolar-endothelial permeability and affecting gas exchange (Zhou et al., 2008; Tao et al., 2009) . Therefore, inhibiting the accumulation of neutrophils in the lung may mitigate ECC-associated ALI (Zhou et al., 2010; Du et al., 2012) .
Tumor necrosis factor-α (TNF-α) is a highly potent proinflammatory cytokine, which is primarily produced by activated macrophages and monocytes (Roach et al., 2002; Du et al., 2012) . The biological functions of TNF-α are involved in the innate immunity, and have a crucial role in pathogenesis of many diseases, such as sepsis. Activation of pulmonary macrophages and release of TNF-α are the earliest manifestations of ALI, which leads to up-regulation of cell surface adhesion molecules and subsequent production of cytokines and chemokines (such as interleukin-6 (IL-6) and IL-8) that induce recruitment of neutrophils within the pulmonary microvasculature (Sedgwick et al., 2000; Mukhopadhyay et al., 2006) . Overexpression of TNF-α is associated with the increased permeability of pulmonary vasculature (Khimenko et al., 1999) . Kotani et al. (2000) have shown that TNF-α mRNA level increases 4-6 folds at the end of ECC. Yende et al. (2003) demonstrated that polymorphisms in the TNF gene (TNF-308) are associated with prolonged mechanical ventilation after a coronary artery bypass graft. Carney et al. (1999) further demonstrated that TNF receptor-binding protein (TNF-bp) significantly reduced plasma TNF levels and reduced the incidence of ARDS following ECC+lipopolysaccharide (LPS) treatment. Recently, we found that the plasma TNF-α level in ARDS patients was significantly higher than that in non-ARDS patients (Li et al., 2012) . These research studies indicated that TNF-α plays an important role in ECC-induced ALI.
TNF-α has multiple receptors, including TNF receptor 1 (TNFR1), TNFR2, Fas (differentiation 95 (CD95) or apoptosis antigen 1 (Apo-1)), and CD40 (Drost and MacNee, 2002) . Previous studies showed that TNFR1 is responsible for neutrophil apoptosis, down-regulates chemokine (C-X-C motif) receptor 2 (CXCR2) expression in neutrophils, and reduces neutrophil infiltration and migration to the infectious site (Secher et al., 2009) . The evidence suggests that TNFR1 pathway plays an important role in inflammatory response associated with neutrophils. In our present study, using an ECC model, we evaluated the role of TNF-TNFR1 pathway in ECC-induced ALI.
Materials and methods

ALI model induced by ECC
ECC was established as reported by Du et al. (2012) . Briefly, male Sprague-Dawley (SD) rats (around 250 g) were anesthetized with pentobarbital (40 mg/kg i.p.), and then ventilated with 40% oxygen. After heparinization (3 mg/kg), the right carotid artery and left femoral vein were cannulated and connected with a roller pump (Stöck II, Munich, Germany) and a tube (1/16 inch internal diameter) primed with Hydroxyethyl Starch 130/0.4. Artery pressure, electrocardiography (ECG), and heart rate were monitored throughout the experiment. All animals were provided by the Animal Experiment Center of Sichuan University, and the protocol was approved by the Animal Hospital Ethics Committee of West China Hospital, Sichuan University, China. Handling of the animals was in compliance with the Guide for the Care and Use of Laboratory Animals.
Study design
In the present study, CAY10500 (Sigma-Aldrich, St. Louis, MO, USA) was used to block the TNF-TNFR1 pathway. CAY10500 is a small-molecule inhibitor of TNF-α, which promotes subunit disassembly of this trimeric cytokine family member to form a dimeric complex, which cannot bind to TNFR1 and thereby inhibit the downstream signaling pathway, for instance, the activation of nuclear factor-кB (NF-кB) (He et al., 2005) .
To test the effect of CAY10500 on TNFR1, neutrophils adhered to vascular endothelial cells induced by TNF-α were detected in vitro according to our previous study Li et al., 2012) . Briefly, blood was collected from a rat vein, and neutrophils were separated by centrifugation with a neutrophil separating medium at 700×g for 30 min at 4 °C. After confirmed by Trypan blue staining, neutrophil yields were incubated in Dulbecco's modified Eagle's medium (DMEM) at 37 °C for 2 h for resting cells.
Vascular endothelial cells (1×10 5 ) were grown in 6-well gelatin-coated plates for 48-72 h, and then the harvested neutrophils were added and stimulated with TNF-α (500 pg/ml; from Peprotech, Rocky Hill, NJ, USA) or TNF-α+CAY10500 (0.075 µmol/L) or placebo for 2 h at 37 °C. The cells were washed three times with PBS, and then assayed by a phase contrast microscopy (Nikon, Melville, NY, USA).
To observe the effect of CAY10500 on pulmonary inflammation, 30 animals were randomly assigned to three groups (n=10 in each group) after establishment of ECC. Rats were pretreated with 0.3 ml Ringer's solution IV in ECC control group, or 0.3 ml ethanol IV in the vehicle group, or 0.3 mg CAY10500 (diluted in 0.3 ml ethanol) in the CAY group. All animals were on ECC for 2 h and monitored for 4 h after ECC and before the sample collection. In addition, 10 animals on ECC for 1 min were sacrificed to obtain their baseline values.
Measurements
Oxygenation index (OI)
Artery blood samples were drawn from the right carotid artery. Artery oxygen partial pressure (PaO 2 ) was measured by ABL800 FLEX (Denmark Radiometer Medical ApS). Then OI was calculated by the formula of PaO 2 /FiO 2 (fraction of inspired oxygen).
Bronchoalveolar lavage fluid (BALF) and cell counts
Bronchoalveolar lavage (BAL) was performed based on Du et al. (2012) at 4 h after ECC. Rats were sacrificed by peritoneal pentobarbital injection. The trachea was cannulated and secured by ligation. Three milliliters of phosphate buffered saline (PBS) were instilled and slowly withdrawn. The collected BALF was centrifuged at 300 r/min for 10 min at 4 °C. Supernatant was stored at −70 °C for future analysis. Precipitate was washed with PBS and resuspended, and then cells were analyzed by an automatic blood cell analyzer (MINDRAY, BC-3000, China).
Determination of TNF-α levels
A blood sample was drawn from the femoral artery and centrifuged at 4 °C. Then 0.5 ml plasma was collected and frozen at −70 °C until later analysis. TNF-α levels in both plasma and BALF were determined by an enzyme-linked immunosorbent assay (ELISA) kit (eBioscience, San Diego, CA, USA) following the manufacturer's instructions.
Histopathological examination of lungs
Tissues were prepared for light microscopy using standard procedures. The histopathological examination of lungs was performed as we reported before (Tao et al., 2009; Zhou et al., 2010; Du et al., 2012) . Briefly, half of the right lungs were rinsed with ice-cold saline. Lung specimens were fixed in 10% formalin, dehydrated, embedded in paraffin, sectioned (3-5 μm), and then stained with hematoxylineosin (H&E). Specimens were examined under a light microscope. Neutrophils were calculated by a blinded observer according to the counts in 30 continuous areas 100 μm from the edge.
Measurement of lung wet/dry weight (WW/DW) ratio
The rest of the right lungs of the animals were excised and weighed, and then placed in an oven at 60 °C for 24 h to obtain their DW. The tissue edema was evaluated through calculation of the WW/DW ratio of the lung tissue.
Statistical analysis
Data were expressed as mean±standard deviation (SD), and the difference between the groups was analyzed by one-way analysis of variance (ANOVA) using SPSS 16.0. P values of less than 0.05 were considered significant.
Results
Effect of CAY10500 on neutrophil adhesion to endothelial cells
Compared with the control, neutrophils adhered to endothelial cells were increased to 2.5-fold under the stimulation of TNF-α (n=6, P<0.01; Fig. 1) , and the adhesive neutrophils were reduced under the treatment of CAY10500 and TNF-α (P<0.01 vs. only TNF-α treatment), suggesting that TNFR1 plays an important role in the adhesion of neutrophils and endothelial cells induced by TNF-α.
Effect of CAY10500 on pulmonary function
Pulmonary function was assessed by OI (Fig. 2) . Compared with the baseline ((438±59) mmHg), OI values were significantly decreased after ECC in both the ECC control group ((285±44) mmHg) and vehicle group ((240±49) mmHg). And they were slightly improved by CAY10500 pretreatment ((318±72) mmHg, P>0.05 vs. the control and vehicle groups).
TNF-α levels in plasma and BALF
Compared with baseline levels ((15.6±5.7) pg/ml), plasma TNF-α levels in the control group increased 10-fold to (157.7±35.0) pg/ml after ECC. Pretreatment of CAY10500 significantly decreased plasma TNF-α levels to (75.5±20.4) pg/ml (P<0.05 vs. the ECC control group; Fig. 3a) .
TNF-α levels in BALF had a similar trend, but significantly higher than those in plasma (P<0.01; Fig. 3) , indicating that the lung may be the main source of TNF-α during ECC. Compared with the baseline level ((109±39) pg/ml), the BALF TNF-α in the control group greatly increased ((642±76) pg/ml, P<0.01) after ECC. Pretreatment of CAY10500 slightly reduced BALF TNF-α ((514±140) pg/ml), but without significant differences (P>0.05; Fig. 3b ).
Neutrophil counts in BALF
Counts of blood leukocytes and neutrophils increased after ECC, but there was no difference between all groups (Fig. 4) .
The amount of neutrophils in BALF was used to assess leukocyte infiltration and ALI. As shown in Fig. 4b Fig. 2 Effect of CAY10500 on pulmonary function Oxygenation index (OI, PaO 2 /FiO 2 ) (a) and blood cell counts (b) were not changed by CAY10500 pretreatment. After establishment of the carotid artery-femoral vein ECC model, rats were treat with PBS (ECC control), or 0.3 ml ethanol (vehicle), or 0.3 mg CAY10500 (CAY). All animals were on ECC for 2 h and monitored for 4 h after ECC, and then PaO 2 and blood cell counts were measured. In addition, 10 animals on ECC for 1 min were sacrificed to obtain the baseline values 
Fig. 5 Lung tissue histology (a) and neutrophil counts (b) in experimental groups
Rats were treated as described in Fig. 2 . Lung tissues were fixed in 10% formalin, dehydrated, embedded in paraffin, sectioned (3-5 μm), and then stained with hematoxylin-eosin (H&E). Specimens were examined under a light microscope. Neutrophils were calculated in 30 continuous areas 100 μm from the edge 
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Pulmonary histopathology
As shown in Fig. 5a , although the alveoli retained their structures, there were significant alveolar congestion, hemorrhage, and infiltration of neutrophils in the airspace, and the thickness of the alveolar wall increased after ECC. Compared with the ECC control and vehicle groups, CAY10500 pretreatment did not change interstitial congestion, but significantly reduced the amount of neutrophils infiltrated (17.6±3.8/high-power field (HPF) vs. 22.4±3.3/HPF, P<0.01; Fig. 5b ).
Lung WW/DW ratio
The WW/DW ratio of lung was (84.2±1.7)% at baseline, and increased after ECC. There was no difference between the ECC control, vehicle, and CAY groups ((87.5±1.32)%, (88.2±1.11)%, and (87.9±1.49)%, respectively).
Discussion
Using an ALI model induced by rat ECC, we found that blocking the TNF-α binding to TNFR1 by CAY10500 inhibited neutrophil adhesion to the endothelial cells induced by TNF-α in vitro, and pretreatment of CAY10500 intravenously in vivo decreased the plasma TNF-α, but did not change the TNF-α levels in the lung tissue. As a result, CAY10500 slightly inhibited leukocyte recruitment and infiltration in the lung, but did not reduce lung edema or improve the lung function after ECC. Our results indicated that the TNFR1 pathway in circulating inflammatory cells played a limited role in ECCinduced ALI.
Other than small animal models as reported before (Wehberg et al., 1996; Doguet et al., 2004) , the rat ECC model was applied to induce ALI in this study. The ECC with carotid artery-femoral vein cannulation did not need allogenic blood priming which could maintain Hb>70 g/L during ECC, and has the advantage of being an easy procedure to avoid disturbance to results caused by surgery . After 4 h of rest following 2 h of ECC procedure, TNF-α levels in plasma and BALF significantly increased, and alveolar congestion, hemorrhage, and infiltration of leukocytes in the airspace, and increased thickness of alveolar wall were seen in lung tissues, indicating that ALI was successfully induced by this ECC model.
The release of TNF-α initiated the release of IL-1, IL-8, and IL-6, as well as the up-regulation of TNF-α, which forms a positive inflammatory feedback (Allen et al., 1992) . Our results showed that TNF-α levels in both plasma and BAL are significantly increased after ECC, indicating TNF-α may mediate both systemic and pulmonary inflammation. By using CAY10500 pretreatment intravenously, TNF-α levels in the blood but not in the lung tissue were reduced. The result suggests that blocking of the circulating TNFR1 pathway inhibits the feedback of inflammation in the blood, but it cannot achieve a high enough concentration for inhibiting positive feedbacks of inflammatory cytokines in lung tissues.
TNF-α increases Mac-1 and intercellular adhesion molecule-1 (ICAM-1) expression, and subsequently induces neutrophil rolling on and adhesion to endothelial cells (Markovic et al., 2009) , followed by neutrophil accumulation and infiltration in the lung tissue. In our present study, with the increase of TNF-α following ECC, typical pulmonary inflammation was seen in the pulmonary pathology. Although our in vitro study showed that blocking of the TNFR1 reduced TNF-α-induced neutrophil adhesion (Berg, 2006) , intravenous pretreatment with CAY10500 inhibited leukocyte accumulation in the lung but did not attenuate ALI induced by ECC. The result suggests that TNFR1 expressed on circulating inflammatory cells mediates neutrophil-endothelial cell adhesion, but plays a limited role in mediating neutrophil migration and infiltration process.
During the migration and infiltration process, neutrophils need recognize chemoattractants to form leading edge and uropod tails (Vicente-Manzanares and Sanchez-Madrid, 2004; Burkhardt et al., 2008; Du et al., 2012) . Therefore, the high chemokine concentration in the lung may play a more important role in localized lung inflammation (Muth et al., 2005) . In the present study, TNF-α levels in BALF were found significantly higher than those in blood (Khimenko et al., 1999) . The concentration gradient of TNF-α between blood and pulmonary interstitial tissue may mediate neutrophil migration and infiltration. However, TNF-α levels in pulmonary interstitial tissue cannot be blocked by CAY10500 intravenous treatment, which explains why the neutrophil infiltration was not inhibited by TNFR1 blocking.
Another reason for the negative results in this study is the complexity of ALI. Previous studies with CAY10500 were only performed with in vitro cells, which avoided complicated cytokines and cell interactions. However, multiple cytokines form a very complicated inflammatory network in vivo, which cannot be inhibited by only blocking TNFR1.
During ECC, local TNF-α in lung tissue may be an important chemoattractant supporting neutrophil infiltration. It was reported that intratracheal instillation of anti-TNF-α antibody attenuated cytomegalovirus (CMV) (Imai et al., 1999) and ECC (Li et al., 2013) induced lung injury. Therefore, intratracheal administration of CAY10500 might achieve a high enough concentration for inhibiting pulmonary inflammation.
In conclusion, although ECC can induce TNF-α release in lung tissue and blood, blocking TNFR1 by intravenous CAY10500 administration cannot inhibit TNF-α release or neutrophil accumulation in the lung. Our results indicated that the TNFR1 pathway in circulating inflammatory cell plays a limited role in ECC-induced ALI.
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